Prediction, management, and prognosis of mixed chimerism after hematopoietic stem cell transplantation in transfusion‐dependent pediatric thalassemia patients
Author:
Affiliation:
1. Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes Sun Yat‐sen University Guangzhou China
2. Department of Pediatrics Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Transplantation,Pediatrics, Perinatology and Child Health
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13876
Reference43 articles.
1. Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy
2. Bone marrow transplantation for aplastic anemia. Establishment of chimerism using multiple HL‐A identical donors following pretreatment with cyclophosphamide;Bortin MM;Transplantation,1971
3. Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance
4. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia;Andreani M;Blood,1996
5. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Uniform graft-versus-host disease prophylaxis using post-transplantation cyclophosphamide, methotrexate, and cyclosporine following peripheral blood hematopoietic stem cell transplantation from matched and haploidentical donors for transfusion-dependent thalassemia: a retrospective report from the BMF-WG of Hunan province, China;Transplantation and Cellular Therapy;2024-09
2. Hemoglobinopathies (Sickle Cell Disease and Thalassemia);The EBMT Handbook;2024
3. Thalassaemia in China;Blood Reviews;2023-07
4. HLA-identical sibling hematopoietic stem cell transplantation following reduced-toxicity myeloablative conditioning regimen in sickle cell disease;2023-05-03
5. Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review;Bone Marrow Transplantation;2022-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3